Abstract
Purpose
Venoarterial extracorporeal membrane oxygenation (V-A ECMO) can be used to support severely ill patients with cardiogenic shock. While age is commonly used in patient selection, little is known regarding its association with outcomes in this population. We sought to evaluate the association between increasing age and outcomes following V-A ECMO.
Methods
We used individual-level patient data from 440 centers in the international Extracorporeal Life Support Organization registry. We included all adult patients receiving V-A ECMO from 2017 to 2019. The primary outcome was hospital mortality. Secondary outcomes included a composite of complications following initiation of V-A ECMO. We conducted Bayesian analyses of the relationship between increasing age and outcomes of interest.
Results
We included 15,172 patients receiving V-A ECMO. Of these, 8172 (53.9%) died in hospital. For the analysis conducted using weakly informed priors, and as compared to the reference category of age 18–29, the age bracket of 30–39 (odds ratio [OR] 0.94, 95% credible interval [CrI] 0.79–1.10) was not associated with hospital mortality, but age brackets 40–49 (odds ratio [OR] 1.26, 95% CrI: 1.08–1.47), 50–59 (OR 1.78, 95% CrI: 1.55–2.06), 60–69 (OR 2.24, 95% CrI: 1.94–2.59), 70–79 (OR 2.90, 95% CrI: 2.49–3.39) and ≥ 80 (OR 4.02, 95% CrI: 3.13–5.20) were independently associated with increasing hospital mortality. Similar results were found in the analysis conducted with an informative prior, as well as between increasing age and post-ECMO complications.
Conclusions
Among patients receiving V-A ECMO for cardiogenic shock, increasing age is strongly associated with increasing odds of death and complications, and this association emerges as early as 40 years of age.
Similar content being viewed by others
References
van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, Kilic A, Menon V, Ohman EM, Sweitzer NK, Thiele H, Washam JB, Cohen MG (2017) contemporary management of cardiogenic shock: a scientific statement from the american heart association. Circulation 136:e232–e268
Berg DD, Bohula EA, van Diepen S, Katz JN, Alviar CL, Baird-Zars VM, Barnett CF, Barsness GW, Burke JA, Cremer PC, Cruz J, Daniels LB, DeFilippis AP, Haleem A, Hollenberg SM, Horowitz JM, Keller N, Kontos MC, Lawler PR, Menon V, Metkus TS, Ng J, Orgel R, Overgaard CB, Park JG, Phreaner N, Roswell RO, Schulman SP, Jeffrey Snell R, Solomon MA, Ternus B, Tymchak W, Vikram F, Morrow DA (2019) Epidemiology of shock in contemporary cardiac intensive care units. Circ Cardiovasc Qual Outcomes 12:e005618
Aissaoui N, Puymirat E, Delmas C, Ortuno S, Durand E, Bataille V, Drouet E, Bonello L, Bonnefoy-Cudraz E, Lesmeles G, Guerot E, Schiele F, Simon T, Danchin N (2020) Trends in cardiogenic shock complicating acute myocardial infarction. Eur J Heart Fail 22:664–672
Fernando SM, Mathew R, Sadeghirad B, Brodie D, Belley-Côté EP, Thiele H, van Diepen S, Fan E, Di Santo P, Simard T, Russo JJ, Tran A, Lévy B, Combes A, Hibbert B, Rochwerg B (2022) Inotropes, vasopressors, and mechanical circulatory support for treatment of cardiogenic shock complicating myocardial infarction: a systematic review and network meta-analysis. Can J Anaesth 69:1537–1553
Combes A, Price S, Slutsky AS, Brodie D (2020) Temporary circulatory support for cardiogenic shock. Lancet 396:199–212
Combes A, Leprince P, Luyt CE, Bonnet N, Trouillet JL, Léger P, Pavie A, Chastre J (2008) Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock. Crit Care Med 36:1404–1411
Eckman PM, Katz JN, El Banayosy A, Bohula EA, Sun B, van Diepen S (2019) Veno-arterial extracorporeal membrane oxygenation for cardiogenic shock: an introduction for the busy clinician. Circulation 140:2019–2037
Karagiannidis C, Brodie D, Strassmann S, Stoelben E, Philipp A, Bein T, Müller T, Windisch W (2016) Extracorporeal membrane oxygenation: evolving epidemiology and mortality. Intensive Care Med 42:889–896
Fernando SM, Qureshi D, Tanuseputro P, Fan E, Munshi L, Rochwerg B, Talarico R, Scales DC, Brodie D, Dhanani S, Guerguerian AM, Shemie SD, Thavorn K, Kyeremanteng K (2019) Mortality and costs following extracorporeal membrane oxygenation in critically ill adults: a population-based cohort study. Intensive Care Med 45:1580–1589
Supady A, Badulak J, Evans L, Curtis JR, Brodie D (2021) Should we ration extracorporeal membrane oxygenation during the COVID-19 pandemic? Lancet Respir Med 9:326–328
Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW (2022) 2022 AHA/ACC/HFSA Guideline for the management of heart failure: a report of the american college of cardiology/American heart association joint committee on clinical practice guidelines. Circulation 145:e895–e1032
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42:3599–3726
Adhikari NK, Fowler RA, Bhagwanjee S, Rubenfeld GD (2010) Critical care and the global burden of critical illness in adults. Lancet 376:1339–1346
Hongisto M, Lassus J, Tarvasmäki T, Sionis A, Sans-Rosello J, Tolppanen H, Kataja A, Jäntti T, Sabell T, Lindholm MG, Banaszewski M, Silva Cardoso J, Parissis J, Di Somma S, Carubelli V, Jurkko R, Masip J, Harjola VP (2021) Mortality risk prediction in elderly patients with cardiogenic shock: results from the CardShock study. ESC Heart Fail 8:1398–1407
Lee SN, Jo MS, Yoo KD (2017) Impact of age on extracorporeal membrane oxygenation survival of patients with cardiac failure. Clin Interv Aging 12:1347–1353
Yeh TC, Chang HH, Ger LP, Wang JO, Kao S, Ho ST (2018) Clinical risk factors of extracorporeal membrane oxygenation support in older adults. PLoS ONE 13:e0195445
Saito S, Nakatani T, Kobayashi J, Tagusari O, Bando K, Niwaya K, Nakajima H, Miyazaki S, Yagihara T, Kitamura S (2007) Is extracorporeal life support contraindicated in elderly patients? Ann Thorac Surg 83:140–145
Schmidt M, Burrell A, Roberts L, Bailey M, Sheldrake J, Rycus PT, Hodgson C, Scheinkestel C, Cooper DJ, Thiagarajan RR, Brodie D, Pellegrino V, Pilcher D (2015) Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score. Eur Heart J 36:2246–2256
Muller G, Flecher E, Lebreton G, Luyt CE, Trouillet JL, Bréchot N, Schmidt M, Mastroianni C, Chastre J, Leprince P, Anselmi A, Combes A (2016) The ENCOURAGE mortality risk score and analysis of long-term outcomes after V-A ECMO for acute myocardial infarction with cardiogenic shock. Intensive Care Med 42:370–378
Chung M, Zhao Y, Strom JB, Shen C, Yeh RW (2019) Extracorporeal membrane oxygenation use in cardiogenic shock: impact of age on in-hospital mortality, length of stay, and costs. Crit Care Med 47:e214–e221
Barbaro RP, MacLaren G, Boonstra PS, Iwashyna TJ, Slutsky AS, Fan E, Bartlett RH, Tonna JE, Hyslop R, Fanning JJ, Rycus PT, Hyer SJ, Anders MM, Agerstrand CL, Hryniewicz K, Diaz R, Lorusso R, Combes A, Brodie D (2020) Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry. Lancet 396:1071–1078
Barbaro RP, MacLaren G, Boonstra PS, Combes A, Agerstrand C, Annich G, Diaz R, Fan E, Hryniewicz K, Lorusso R, Paden ML, Stead CM, Swol J, Iwashyna TJ, Slutsky AS, Brodie D (2021) Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international extracorporeal life support organization registry. Lancet 398:1230–1238
Lederer DJ, Bell SC, Branson RD, Chalmers JD, Marshall R, Maslove DM, Ost DE, Punjabi NM, Schatz M, Smyth AR, Stewart PW, Suissa S, Adjei AA, Akdis CA, Azoulay É, Bakker J, Ballas ZK, Bardin PG, Barreiro E, Bellomo R, Bernstein JA, Brusasco V, Buchman TG, Chokroverty S, Collop NA, Crapo JD, Fitzgerald DA, Hale L, Hart N, Herth FJ, Iwashyna TJ, Jenkins G, Kolb M, Marks GB, Mazzone P, Moorman JR, Murphy TM, Noah TL, Reynolds P, Riemann D, Russell RE, Sheikh A, Sotgiu G, Swenson ER, Szczesniak R, Szymusiak R, Teboul JL, Vincent JL (2019) Control of confounding and reporting of results in causal inference studies. guidance for authors from editors of respiratory, sleep, and critical care journals. Ann Am Thorac Soc 16:22–28
Althouse AD, Below JE, Claggett BL, Cox NJ, de Lemos JA, Deo RC, Duval S, Hachamovitch R, Kaul S, Keith SW, Secemsky E, Teixeira-Pinto A, Roger VL (2021) Recommendations for statistical reporting in cardiovascular medicine: a special report from the American heart association. Circulation 144:e70–e91
Hayden JA, van der Windt DA, Cartwright JL, Côté P, Bombardier C (2013) Assessing bias in studies of prognostic factors. Ann Intern Med 158:280–286
Depaoli S, van de Schoot R (2017) Improving transparency and replication in Bayesian statistics: the WAMBS-Checklist. Psychol Methods 22:240–261
Collins GS, Reitsma JB, Altman DG, Moons KG (2015) Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement. Ann Intern Med 162:55–63
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP (2007) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370:1453–1457
Sung L, Hayden J, Greenberg ML, Koren G, Feldman BM, Tomlinson GA (2005) Seven items were identified for inclusion when reporting a Bayesian analysis of a clinical study. J Clin Epidemiol 58:261–268
Ouweneel DM, Schotborgh JV, Limpens J, Sjauw KD, Engström AE, Lagrand WK, Cherpanath TGV, Driessen AHG, de Mol B, Henriques JPS (2016) Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis. Intensive Care Med 42:1922–1934
Grandin EW, Nunez JI, Willar B, Kennedy K, Rycus P, Tonna JE, Kapur NK, Shaefi S, Garan AR (2022) Mechanical left ventricular unloading in patients undergoing venoarterial extracorporeal membrane oxygenation. J Am Coll Cardiol 79:1239–1250
Kowalewski M, Zieliński K, Maria Raffa G, Meani P, Lo Coco V, Jiritano F, Fina D, Matteucci M, Chiarini G, Willers A, Simons J, Suwalski P, Gaudino M, Di Mauro M, Maessen J, Lorusso R (2021) Mortality predictors in elderly patients with cardiogenic shock on venoarterial extracorporeal life support. analysis from the extracorporeal life support organization registry. Crit Care Med 49:7–18
Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA (2004) New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol 57:1288–1294
Rubin DB (1987) Multiple Imputation for Nonresponse in Surveys. Wiley, New York, NY
Bürkner P-C (2017) brms: an r package for bayesian multi-level models using stan. J Stat Softw 80:1–27
Austin PC (2009) Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat Simul Comput 38:1228–1234
Gelman A, Jakulin A, Pittau MG, Su Y (2008) A weakly informative default prior distribution for logistic and other regression models. Ann Appl Stat 2:1360–1383
Kurella M, Covinsky KE, Collins AJ, Chertow GM (2007) Octogenarians and nonagenarians starting dialysis in the United States. Ann Intern Med 146:177–183
Stretch R, Sauer CM, Yuh DD, Bonde P (2014) National trends in the utilization of short-term mechanical circulatory support: incidence, outcomes, and cost analysis. J Am Coll Cardiol 64:1407–1415
Strom JB, Zhao Y, Shen C, Chung M, Pinto DS, Popma JJ, Yeh RW (2018) National trends, predictors of use, and in-hospital outcomes in mechanical circulatory support for cardiogenic shock. EuroIntervention 13:e2152–e2159
Pladet LCA, Barten JMM, Vernooij LM, Kraemer CVE, Bunge JJH, Scholten E, Montenij LJ, Kuijpers M, Donker DW, Cremer OL, Meuwese CL (2023) Prognostic models for mortality risk in patients requiring ECMO. Intensive Care Med 49:131–141
Keebler ME, Haddad EV, Choi CW, McGrane S, Zalawadiya S, Schlendorf KH, Brinkley DM, Danter MR, Wigger M, Menachem JN, Shah A, Lindenfeld J (2018) Venoarterial extracorporeal membrane oxygenation in cardiogenic shock. JACC Heart Fail 6:503–516
Haas B, Wunsch H (2016) How does prior health status (age, comorbidities and frailty) determine critical illness and outcome? Curr Opin Crit Care 22:500–505
Muscedere J, Waters B, Varambally A, Bagshaw SM, Boyd JG, Maslove D, Sibley S, Rockwood K (2017) The impact of frailty on intensive care unit outcomes: a systematic review and meta-analysis. Intensive Care Med 43:1105–1122
Jung C, Guidet B, Flaatten H (2023) Frailty in intensive care medicine must be measured, interpreted and taken into account! Intensive Care Med 49:87–90
Lorusso R, Gelsomino S, Parise O, Mendiratta P, Prodhan P, Rycus P, MacLaren G, Brogan TV, Chen YS, Maessen J, Hou X, Thiagarajan RR (2017) Venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock in elderly patients: trends in application and outcome from the extracorporeal life support organization (ELSO) registry. Ann Thorac Surg 104:62–69
Zangrillo A, Landoni G, Biondi-Zoccai G, Greco M, Greco T, Frati G, Patroniti N, Antonelli M, Pesenti A, Pappalardo F (2013) A meta-analysis of complications and mortality of extracorporeal membrane oxygenation. Crit Care Resusc 15:172–178
Jentzer JC, van Diepen S, Barsness GW, Henry TD, Menon V, Rihal CS, Naidu SS, Baran DA (2019) Cardiogenic shock classification to predict mortality in the cardiac intensive care unit. J Am Coll Cardiol 74:2117–2128
Hodgson CL, Higgins AM, Bailey MJ, Anderson S, Bernard S, Fulcher BJ, Koe D, Linke NJ, Board JV, Brodie D, Buhr H, Burrell AJC, Cooper DJ, Fan E, Fraser JF, Gattas DJ, Hopper IK, Huckson S, Litton E, McGuinness SP, Nair P, Orford N, Parke RL, Pellegrino VA, Pilcher DV, Sheldrake J, Reddi BAJ, Stub D, Trapani TV, Udy AA, Serpa Neto A (2022) Incidence of death or disability at 6 months after extracorporeal membrane oxygenation in Australia: a prospective, multicentre, registry-embedded cohort study. Lancet Respir Med 10:1038–1048
Fernando SM, Scott M, Talarico R, Fan E, McIsaac DI, Sood MM, Myran DT, Herridge MS, Needham DM, Hodgson CL, Rochwerg B, Munshi L, Wilcox ME, Bienvenu OJ, MacLaren G, Fowler RA, Scales DC, Ferguson ND, Combes A, Slutsky AS, Brodie D, Tanuseputro P, Kyeremanteng K (2022) Association of extracorporeal membrane oxygenation with new mental health diagnoses in adult survivors of critical illness. JAMA 328:1827–1836
Funding
Authors did not received any funding for this work.
Author information
Authors and Affiliations
Contributions
SMF, GM, DB, and DIM conceived the study idea. All authors participated in study design. DIM performed data analyses. All authors interpreted the data analyses. All authors co-wrote and revised the manuscript for intellectual content. All authors provided their final approval for manuscript submission. All authors agree to be accountable for all aspects of the work. SMF and GM are co-first authors. DB and DIM are co-senior authors.
Corresponding author
Ethics declarations
Conflicts of interest
SMF has no conflicts to declare. GML is President of the Extracorporeal Life Support Organization (ELSO). RPB is the ELSO Registry Chair. RM has no conflicts to declare. LM has no conflicts to declare. PM has no conflicts to declare. JAF has no conflicts to declare. KR is Co-Chair of the ELSO Scientific Oversight Committee. RL is a consultant and conducts clinical trials for LivaNova. He receives research support from Medtronic, and serves as a consultant for Medtronic, Getinge, and Abiomed. He serves on the medical advisory boards of Fresenius, Hemocue, and Eurosets. DB receives research support from and consults for LivaNova. He has been on the medical advisory boards for Abiomed, Xenios, Medtronic, Inspira and Cellenkos. He is the President-elect of the Extracorporeal Life Support Organization (ELSO) and the Chair of the Executive Committee of the International ECMO Network (ECMONet), and he writes for UpToDate. DIMcI receives salary support from The Ottawa Hospital Anesthesia Alternate Funds Association and holds a Research Chair from the University of Ottawa Faculty of Medicine.
Ethical approval
Not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Fernando, S.M., MacLaren, G., Barbaro, R.P. et al. Age and associated outcomes among patients receiving venoarterial extracorporeal membrane oxygenation–analysis of the Extracorporeal Life Support Organization registry. Intensive Care Med 49, 1456–1466 (2023). https://doi.org/10.1007/s00134-023-07199-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-023-07199-1